Rakesh Rawal, Chief Executive Officer of Anand Rathi Wealth, said the company has reported strong growth for the quarter despite the challenging market scenario.
Pharma shares may be in focus as India's apex health research organization ICMR has raised concerns around the safety for use of the oral antiviral drug Molnupiravir
NBFCs to come under the ambit of PCA framework from Oct 2022; Anand Rathi Wealth debuts at 9% premium; WPI-based inflation hits 12-year high of 14.2% in Nov
Reliance, Bharti Airtel and financial shares were the other major losers; Data Patterns IPO gets 2.5 times subscripton as of 03:15 PM on day 1 of the offer